Ismaı̈l Elalamy

9.3k total citations · 1 hit paper
241 papers, 4.9k citations indexed

About

Ismaı̈l Elalamy is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ismaı̈l Elalamy has authored 241 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Internal Medicine, 114 papers in Hematology and 80 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ismaı̈l Elalamy's work include Venous Thromboembolism Diagnosis and Management (123 papers), Blood Coagulation and Thrombosis Mechanisms (64 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (46 papers). Ismaı̈l Elalamy is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (123 papers), Blood Coagulation and Thrombosis Mechanisms (64 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (46 papers). Ismaı̈l Elalamy collaborates with scholars based in France, Russia and Italy. Ismaı̈l Elalamy's co-authors include Grigoris Gerotziafas, Theodoros Ν. Sergentanis, Meletios Α. Dimopoulos, Evangelos Terpos, Θεοδώρα Ψαλτοπούλου, Efstathios Kastritis, Ioannis Ntanasis‐Stathopoulos, Marianna Politou, M Samama and Mohamed Hatmi and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ismaı̈l Elalamy

216 papers receiving 4.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hematological findings and complications of COVID‐19

2020 1.1k citations Ismaı̈l Elalamy, Grigoris Gerotziafas et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ismaı̈l Elalamy France	32	1.8k	1.3k	1.3k	1.2k	884	241	4.9k
Grigoris Gerotziafas France	30	1.7k 0.9×	1.3k 1.0×	1.2k 0.9×	1.1k 0.9×	799 0.9×	163	4.3k
Michiel Coppens Netherlands	29	2.0k 1.1×	894 0.7×	1.8k 1.3×	1.4k 1.1×	600 0.7×	134	4.5k
Marieke J.H.A. Kruip Netherlands	26	2.5k 1.4×	3.6k 2.7×	1.2k 0.9×	1.0k 0.8×	868 1.0×	137	7.1k
Veena Chantarangkul Italy	36	1.3k 0.7×	803 0.6×	857 0.7×	1.9k 1.5×	1.1k 1.2×	115	5.7k
Jean M. Connors United States	41	3.5k 2.0×	2.7k 2.0×	2.7k 2.1×	1.6k 1.3×	1.7k 1.9×	228	8.9k
Alexander P. J. Vlaar Netherlands	38	591 0.3×	1.2k 0.9×	861 0.7×	592 0.5×	1.2k 1.4×	256	6.8k
Corinne Frère France	33	1.1k 0.6×	395 0.3×	2.5k 1.9×	625 0.5×	1.3k 1.5×	122	4.3k
Alejandro Lazo‐Langner Canada	29	1.6k 0.9×	308 0.2×	1.0k 0.8×	696 0.6×	588 0.7×	169	3.2k
Ravi Sarode United States	43	1.6k 0.9×	321 0.2×	2.2k 1.7×	2.9k 2.3×	1.2k 1.4×	221	8.3k
Hunter B. Moore United States	39	688 0.4×	851 0.6×	357 0.3×	593 0.5×	1.3k 1.5×	192	6.3k

Countries citing papers authored by Ismaı̈l Elalamy

Since Specialization

Citations

This map shows the geographic impact of Ismaı̈l Elalamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ismaı̈l Elalamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ismaı̈l Elalamy more than expected).

Fields of papers citing papers by Ismaı̈l Elalamy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ismaı̈l Elalamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ismaı̈l Elalamy. The network helps show where Ismaı̈l Elalamy may publish in the future.

Co-authorship network of co-authors of Ismaı̈l Elalamy

This figure shows the co-authorship network connecting the top 25 collaborators of Ismaı̈l Elalamy. A scholar is included among the top collaborators of Ismaı̈l Elalamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ismaı̈l Elalamy. Ismaı̈l Elalamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Бицадзе, В. О., J. Kh. Khizroeva, M. V. Tretyakova, et al.. (2025). Cerebral vein thrombosis: management tactics with a focus on pregnancy, the use of hormone therapy and assisted reproductive technologies. The Journal of Maternal-Fetal & Neonatal Medicine. 38(1). 2447349–2447349.

Khizroeva, J. Kh., M. V. Tretyakova, В. И. Цибизова, et al.. (2024). Pediatric antiphospholipid syndrome: is it the same as an adult?. The Journal of Maternal-Fetal & Neonatal Medicine. 37(1). 2390637–2390637.

Makatsariya, А. D., В. О. Бицадзе, А. Г. Солопова, et al.. (2024). The concept of thromboinflammation underlying thrombotic complications, tumor progression and metastasis in gynecological cancer patients. SHILAP Revista de lepidopterología. 18(4). 450–463. 2 indexed citations

Khizroeva, J. Kh., et al.. (2024). Antiphospholipid antibodies as a potential factor of tumor progression. SHILAP Revista de lepidopterología. 18(1). 8–22.

Бицадзе, В. О., А. Г. Солопова, J. Kh. Khizroeva, et al.. (2023). Immunothrombosis in cancer patients: contribution of neutrophil extracellular traps, ADAMTS-13 and von Willebrand factor. SHILAP Revista de lepidopterología. 16(6). 648–663. 2 indexed citations

Бицадзе, В. О., J. Kh. Khizroeva, В. И. Цибизова, et al.. (2023). Dysregulated platelet function in COVID-19 patients. SHILAP Revista de lepidopterología. 16(6). 692–705. 1 indexed citations

Бицадзе, В. О., J. Kh. Khizroeva, M. V. Tretyakova, et al.. (2021). Features of nervous system damage in antiphospholipid syndrome. SHILAP Revista de lepidopterología. 15(4). 404–414. 1 indexed citations

Бицадзе, В. О., J. Kh. Khizroeva, M. V. Tretyakova, et al.. (2021). Risk Factors in Cancer Patients. Annals of the Russian academy of medical sciences. 76(5). 465–475. 2 indexed citations

Makatsariya, А. D., В. О. Бицадзе, J. Kh. Khizroeva, et al.. (2021). Neutrophil extracellular traps: a role in inflammation and dysregulated hemostasis as well as in patients with COVID-19 and severe obstetric pathology. SHILAP Revista de lepidopterología. 15(4). 335–350. 5 indexed citations

10.

Tardy, Brigitte, Michèle Piot, Martine Alhenc‐Gelas, et al.. (2021). Functional Flow Cytometric Assay for Reliable and Convenient Heparin-Induced Thrombocytopenia Diagnosis in Daily Practice. Biomedicines. 9(4). 332–332. 7 indexed citations

11.

Harenberg, Job, Jan Beyer‐Westendorf, Mark Crowther, et al.. (2019). Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine—A Multicenter Trial. Thrombosis and Haemostasis. 120(1). 132–140. 25 indexed citations

12.

Tomer, Aaron, et al.. (2017). Sensitive and Specific Functional Flow Cytometry Assay for Rapid Diagnosis of Heparin Induced Thrombocytopenia and Thrombosis (HIT). Blood. 130. 2341–2341. 1 indexed citations

13.

Hanon, Olivier, et al.. (2017). Real-Life Peak and Trough Dabigatran Plasma Measurements Over Time in Hospitalized Geriatric Patients with Atrial Fibrillation. The journal of nutrition health & aging. 22(1). 165–173. 14 indexed citations

14.

Zafrani, Lara, Grigoris Gerotziafas, Colleen Byrnes, et al.. (2012). Calpastatin Controls Polymicrobial Sepsis by Limiting Procoagulant Microparticle Release. American Journal of Respiratory and Critical Care Medicine. 185(7). 744–755. 49 indexed citations

15.

Chakroun, Tahar, et al.. (2011). The Cyclooxygenase-1 C50T Polymorphism Is Not Associated with Aspirin Responsiveness Status in Stable Coronary Artery Disease in Tunisian Patients. Genetic Testing and Molecular Biomarkers. 15(7-8). 513–516. 8 indexed citations

16.

Rousseau, Alexandra, Annie Robert, Grigoris Gerotziafas, et al.. (2009). Effect of two oral doses of 17β‐estradiol associated with dydrogesterone on thrombin generation in healthy menopausal women: a randomized double‐blind placebo‐controlled study. Fundamental and Clinical Pharmacology. 24(2). 239–245. 2 indexed citations

17.

Debourdeau, P., Grégoire Le Gal, Irène Kriegel, et al.. (2009). 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group. Annals of Oncology. 20(9). 1459–1471. 95 indexed citations

18.

Elalamy, Ismaı̈l, Grigoris Gerotziafas, Anna D. Petropoulou, et al.. (2007). Circulating platelet–leukocyte aggregates: A marker of microvascular injury in diabetic patients. Thrombosis Research. 121(6). 843–848. 57 indexed citations

19.

Salmi, Louis‐Rachid, Ismaı̈l Elalamy, Catherine Leroy‐Matheron, et al.. (2005). Thrombose d’un circuit de circulation extracorporelle sous danaparoïde sodique à la phase aiguë d’une thrombopénie induite par l’héparine de type II en dépit d’une hypocoagulation recommandée. Annales Françaises d Anesthésie et de Réanimation. 25(11-12). 1144–1148. 7 indexed citations

20.

Samama, M, Dietmar Simon, MH Horellou, et al.. (1996). Diagnosis And Clinical Characteristics Of Inherited Activated Protein C Resistance. Pathophysiology of Haemostasis and Thrombosis. 26(Suppl. 4). 315–330. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact